Customized research for ARPO vs. EGRX!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ARPO vs. EGRX.


↗ Join Our Free Email Newsletter.




Aerpio Pharmaceuticals Inc. vs. Eagle Pharmaceuticals Inc.

Industry Match! Industry of Both ARPO and EGRX:

Health Care/Life Sciences

ARPO

Key Statistics

Cap: 159.483M


P/E: N/A

P/S: 13.82

Q P/B: 2.4

Y Rev: 11.54M

Q Rev: 18.82M

Beta: N/A

ARPO Share Stats

Outstanding Shares

40.6M

Float Shares

11.08M

Percent of Float Short

0.05%

ARPO Insider Stats

Percent Outstanding Insider Ownership

1.15%

Percent Outstanding Institution Ownership

30.18%

ARPO Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ARPO in Pulse Portal

Stream of Posts

ARPO Symbol Page

Share ARPO Insights

Express Sentiment

'Buy' or 'Sell' ARPO

ARPO Profile

CEO

Mr. Muneer A. Satter

Exchange

Nasdaq

Employees

25.00

About

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its lead program include a Tie2 activator for diabetic retinopathy and hypoxia-inducible factor. The company was founded by Joseph...

ARPO Financials

Annual Financials

Income Statement

Revenue

11.54M

Net Income

292.61%

Cash Flow Statement

Change in Cash / Investments

18.65M

Balance Sheet

Cash / Investments

20.26M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

20.9M

Total Current Liabilities

3.59M

Total Assets

21.03M

Total Liabilities

3.59M

Stockholder Equity

17.44M

Quarterly Financials

Income Statement

Q Revenue

18.82M

Q Net Income

11.54M

Cash Flow Statement

Q Change in Cash / Investments

24,057

Balance Sheet

Q Cash / Investments

68.81M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

70.04M

Q Total Current Liabilities

3.64M

Q Total Assets

70.16M

Q Total Liabilities

3.64M

Q Stockholder Equity

66.52M

ARPO Charts

10-Year Chart

ARPO 10-Year Chart

5-Year Chart

ARPO 5-Year Chart

1-Year Chart

ARPO 1-Year Chart

6-Month Chart

ARPO 6-Month Chart

3-Month Chart

ARPO 3-Month Chart

1-Month Chart

ARPO 1-Month Chart

1-Day Chart

ARPO 1-Day Chart

EGRX

Key Statistics

Cap: 772.802M


P/E: 24.79

P/S: 3.26

Q P/B: 3.98

Y Rev: 236.71M

Q Rev: 51.34M

Beta: 1.48

EGRX Share Stats

Outstanding Shares

14.86M

Float Shares

12.79M

Percent of Float Short

20.81%

EGRX Insider Stats

Percent Outstanding Insider Ownership

11.42%

Percent Outstanding Institution Ownership

N/A

EGRX Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

EGRX in Pulse Portal

Stream of Posts

EGRX Symbol Page

Share EGRX Insights

Express Sentiment

'Buy' or 'Sell' EGRX

EGRX Profile

CEO

Mr. Michael Graves

Exchange

Nasdaq

Employees

108.00

About

Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban; ryanodex; docetaxel injection, non-alcohol formulation; and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in...

EGRX Financials

Annual Financials

Income Statement

Revenue

236.71M

Net Income

51.94M

Cash Flow Statement

Change in Cash / Investments

61.84M

Balance Sheet

Cash / Investments

114.66M

Short Term Debt

None

Long Term Debt

42.91M

Total Current Assets

188.7M

Total Current Liabilities

47.3M

Total Assets

273.11M

Total Liabilities

93.97M

Stockholder Equity

179.14M

Quarterly Financials

Income Statement

Q Revenue

51.34M

Q Net Income

14.04M

Cash Flow Statement

Q Change in Cash / Investments

(9.02M)

Balance Sheet

Q Cash / Investments

91.23M

Q Short Term Debt

None

Q Long Term Debt

39.31M

Q Total Current Assets

197.77M

Q Total Current Liabilities

35.41M

Q Total Assets

268.79M

Q Total Liabilities

74.72M

Q Stockholder Equity

194.07M

EGRX Charts

10-Year Chart

EGRX 10-Year Chart

5-Year Chart

EGRX 5-Year Chart

1-Year Chart

EGRX 1-Year Chart

6-Month Chart

EGRX 6-Month Chart

3-Month Chart

EGRX 3-Month Chart

1-Month Chart

EGRX 1-Month Chart

1-Day Chart

EGRX 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon